GlassScriptPhysician profile
Steven Fletcher
NPI 1063412781
$375.60
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $93.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $195.34 | 2019-2020 | |
| Stryker Corporation | $40.50 | 2019-2020 | |
| Genzyme Corporation | $27.44 | 2020 | |
| Aerin Medical INC. | $26.47 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $22.39 | 2019 | |
| Greer Laboratories, INC. | $19.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.90 | 2019 | |
| Alk-Abello, INC | $14.03 | 2019 | |
| Kaleo, INC. | $11.76 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Fletcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.